Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
Clinical trial NCT03377491 · COMPLETED
Trial details
- NCT number
- NCT03377491
- Sponsor
- NovoCure Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2024-10-16
- Enrollment
- 571
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.